Clinical Trial Update: Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating peptide-coupled red blood cells for relapsing-remitting multiple sclerosis, sponsored by Cellerys AG, which is currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Peptide-coupled Red Blood Cells (peptide-coupled red blood cells)

Snippet

Sponsor: Cellerys AG | Conditions: Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 1 | Status: ACTIVE_NOT_RECRUITING